Checkpoint Therapeutics Stock
Price
Target price
-
-
-
-
-
?30.87
WKN: A2JAHK / Symbol: CKPT / Name: Checkpoint Therapeutics / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Checkpoint Therapeutics Stock
With 7 Buy predictions and not the single Sell prediction the community is currently very high on Checkpoint Therapeutics.
Based on the current price of 0.5 € the target price of 30 € shows a potential of 5885.63% for Checkpoint Therapeutics which would more than double the current price.
Pros and Cons of Checkpoint Therapeutics in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
B****
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Checkpoint Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Checkpoint Therapeutics | - | - | - | - | - | - | - |
| Ardelyx Inc. | 3.900% | -2.578% | -17.883% | 40.048% | 2.007% | -13.927% | - |
| Salarius Pharmaceuticals Inc. | 1.400% | -2.727% | -46.500% | -69.209% | -22.883% | -98.244% | -99.994% |
| Brainstorm Cell | -5.760% | 3.754% | -21.032% | -81.975% | 114.440% | -80.717% | - |
Comments
Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $34.00 price target on the stock.
Show more
Ratings data for CKPT provided by MarketBeat
Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) had its price target lowered by analysts at B. Riley from $8.00 to $4.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CKPT provided by MarketBeat
Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $34.00 price target on the stock.
Show more
Ratings data for CKPT provided by MarketBeat